Troy Edward Wilson
Net Worth

Last updated:

What is Troy Edward Wilson net worth?

The estimated net worth of Dr. Troy Edward Wilson is at least $25,473,121 as of 26 Sep 2025. He owns shares worth $4,097 as insider, has earned $16,457,024 from insider trading and has received compensation worth at least $9,012,000 in Avidity Biosciences, Inc. and Kura Oncology, Inc..

What is the salary of Troy Edward Wilson?

Dr. Troy Edward Wilson salary is $1,110,000 per year as Chairman, Chief Executive Officer & Pres in Kura Oncology, Inc.. He also receives $132,000 as Co-Founder & Chairman in Avidity Biosciences, Inc..

How old is Troy Edward Wilson?

Dr. Troy Edward Wilson is 56 years old, born in 1969.

What stocks does Troy Edward Wilson currently own?

As insider, Dr. Troy Edward Wilson owns shares in one company:

Company Title Shares Price per share Total value
Kura Oncology, Inc. (KURA) Chairman, Chief Executive Officer & Pres 559 $7.33 $4,097

What does Kura Oncology, Inc. do?

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

KURA logo
KURA
Kura Oncology, Inc.
$7.33

Troy Edward Wilson insider trading

Kura Oncology, Inc.

Dr. Troy Edward Wilson has made 18 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 84,107 units of KURA stock worth $1,701,485 on 24 Jan 2024.

The largest trade he's ever made was exercising 157,106 units of KURA stock on 8 Oct 2020. As of 26 Sep 2025 he still owns at least 559 units of KURA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 84,107 $20.23 $1,701,485
Option
Common Stock 84,107 $6.15 $517,258
Option
Common Stock 6,945 $4.8 $33,336
Option
Common Stock 11,855 $6.15 $72,908
Option
Option to purchase common stock 11,855 $6.15 $72,908
Option
Option to purchase common stock 50,370 $34 $1,712,580
Sale
Common Stock 157,106 N/A N/A
Option
Common Stock 50,370 $34 $1,712,580
Sale
Common Stock 157,106 $34 $5,341,604
Sale
Common Stock 104,486 N/A N/A
Option
Common Stock 4,586 $6.15 $28,204
Option
Option to purchase common stock 4,586 $6.15 $28,204
Sale
Common Stock 104,486 $19.08 $1,993,070
Sale
Common Stock 100 $32 $3,200
Sale
Common Stock 98,490 $28.82 $2,838,876
Sale
Common Stock 18,411 $17.08 $314,368
Option
Option to purchase common stock 17,926 $6.15 $110,245
Option
Common Stock 17,926 $6.15 $110,245
Sale
Common Stock 18,411 N/A N/A
Sale
Common Stock 38,055 $17.08 $649,789
Option
Common Stock 37,030 $6.15 $227,735
Option
Option to purchase common stock 37,030 $6.15 $227,735
Sale
Common Stock 38,055 $17.08 $649,789
Sale
Common Stock 50,000 $26 $1,300,000
Sale
Common Stock 23,053 $22.37 $515,788
Option
Option to purchase common stock 23,053 $5.48 $126,215
Option
Common Stock 23,053 $5.48 $126,215
Option
Common Stock 23,053 $5.48 $126,215
Option
Option to purchase common stock 23,053 $5.48 $126,215
Option
Option to purchase common stock 6,568 $4.8 $31,526
Option
Common Stock 6,568 $4.8 $31,526
Sale
Common Stock 6,568 $4.8 $31,526
Option
Common Stock 11,913 $22.09 $263,194
Option
Option to purchase common stock 11,913 $22.09 $263,194
Sale
Common Stock 11,913 $22.09 $263,194
Sale
Common Stock 521 $22 $11,462
Option
Common Stock 521 $22 $11,462
Option
Option to purchase common stock 521 $22 $11,462
Option
Option to purchase common stock 12,901 $4.8 $61,925
Option
Common Stock 12,901 $4.8 $61,925
Sale
Common Stock 62,901 N/A N/A
Sale
Common Stock 62,901 $13.4 $842,873
Option
Option to purchase common stock 28,096 $5.48 $153,826
Option
Common stock 28,096 $5.48 $153,826
Option
Option to purchase common stock 26,041 $4.8 $124,997
Option
Common Stock 26,041 $4.8 $124,997
Option
Option to purchase common stock 27,985 $4.8 $134,328
Option
Common Stock 27,985 $4.8 $134,328
Option
Common Stock 5,000 $4.8 $24,000
Option
Option to purchase common stock 5,000 $4.8 $24,000

Avidity Biosciences key executives

Avidity Biosciences, Inc. executives and other stock owners filed with the SEC: